The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others.
Stegent Equity Advisors Inc. bought a new position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor bought 3,193 shares of the company’s stock, valued at approximately $330,000. Several other institutional investors have also recently made changes to their positions in NVO. Westside Investment Management […]
Stegent Equity Advisors Inc. purchased a new stake in Novo Nordisk A/S (NYSE:NVO – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 3,193 shares of the company’s stock, valued at approximately $330,000. A number of other hedge funds have also made changes […]
Eagle Ridge Investment Management boosted its stake in Novo Nordisk A/S (NYSE:NVO – Free Report) by 17.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,712 shares of the company’s stock after acquiring an additional 562 shares during the quarter. Eagle Ridge Investment Management’s holdings in […]